山东鲁抗医药股份有限公司 2025年第三季度报告

Core Points - The board of directors and senior management of the company guarantee the authenticity, accuracy, and completeness of the quarterly report, and they bear legal responsibility for any false records, misleading statements, or significant omissions [1] - The quarterly financial report has not been audited, and there are no non-standard opinions from auditors [2] - The company has identified non-recurring gains and losses, and it is applicable to disclose significant items that are not listed in the relevant announcement [3] - There are changes in major accounting data and financial indicators, and the reasons for these changes are applicable to be disclosed [4] - The company has provided information regarding the total number of ordinary shareholders and the top ten shareholders, but there are no changes due to securities lending [5] - The financial statements, including the consolidated balance sheet, profit statement, and cash flow statement, are prepared by the company and are unaudited [6]